For breast cancer, overexpression of CCNE1 have been verified as an early event of breast cancer progression (Shaye et al., 2009), and high level of CCNE1 is often associated with poor prognosis (Fredholm et al., 2017). The gene discussed is CCNE1; the disease is breast cancer.